SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-281296
Filing Date
2022-11-09
Accepted
2022-11-09 16:50:34
Documents
18
Period of Report
2022-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d376864d8k.htm   iXBRL 8-K 36953
2 EX-5.1 d376864dex51.htm EX-5.1 9542
3 EX-10.1 d376864dex101.htm EX-10.1 174719
4 EX-10.2 d376864dex102.htm EX-10.2 98007
5 EX-10.3 d376864dex103.htm EX-10.3 72922
6 EX-10.4 d376864dex104.htm EX-10.4 73699
10 GRAPHIC g376864g84t90.jpg GRAPHIC 10172
  Complete submission text file 0001193125-22-281296.txt   728506

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bior-20221106.xsd EX-101.SCH 2876
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20221106_lab.xml EX-101.LAB 18739
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20221106_pre.xml EX-101.PRE 11721
12 EXTRACTED XBRL INSTANCE DOCUMENT d376864d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 221373410
SIC: 2834 Pharmaceutical Preparations